Sanfetrinem (sodium)

Sanfetrinem (GV104326) sodium is a beta-lactamase-stable antibiotic. Sanfetrinem sodium has broad-spectrum activity against gram-positive and gram-negative bacteria[1].

Product Specifications

CAS Number

[141611-76-9]

Product Name Alternative

GV104326 (sodium)

UNSPSC

12352005

Hazard Statement

H317, H334

Target

Antibiotic; Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/sanfetrinem-sodium.html

Purity

95.0

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

C[C@H]([C@]1([H])[C@]2([H])N(C(C(O[Na])=O)=C3[C@]2([H])CCC[C@@H]3OC)C1=O)O

Molecular Formula

C14H18NNaO5

Molecular Weight

303.29

Precautions

H317, H334

References & Citations

[1]Betriu C, et al. Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents. Antimicrob Agents Chemother. 1999 Sep;43 (9) :2320-2.|[2]Tamura S, et al. In vivo antibacterial activities of sanfetrinem cilexetil, a new oral tricyclic antibiotic. Antimicrob Agents Chemother. 1998 Jul;42 (7) :1858-61.